Sudhir Sethi Acquires 7500 Beryl Drugs Shares

Beryl Drugs Limited discloses promoter Sudhir Sethi's acquisition of 7,500 equity shares (0.14%) via open market on 23 March 2026.
Post-acquisition, Sudhir Sethi's holding in Beryl Drugs rises from 9.44% (4,78,983 shares) to 9.58% (4,86,483 shares).
Disclosure filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 with BSE Ltd.